CANCER CENTER ADMINISTRATION - ABSTRACT Administration at the Karmanos Cancer Institute (KCI) provides support to the Cancer Center leadership, Research Program and Shared Resource infrastructure, KCI membership, and staff by providing services aimed at relieving the administrative burden associated with research. Administration contributes to the mission of the Cancer Center by providing efficient management of resources, facilitating key internal and external scientific meetings, strategic planning, and developing useful metrics to aid in the decision making of KCI senior leadership. Mr. Evano Piasentin, Associate Center Director for Research Administration, leads an experienced administrative team. Administration supports 135 scientific members across four research Programs and nine Shared Resources (including one under development). Additionally, Administration manages extramural funding of $63 million (annual direct costs), KCI?s annual research budget of $21 million, and coordinated internal pilot funding of more than $2 million since the last renewal. Notable achievements during the past funding period include a restructuring of the administrative office to capitalize on the unique skills of staff and provide a more efficient and dynamic environment to meet the needs of the Cancer Center. Additionally, Administration supported the planning, process, and development of a new strategic plan through organization of strategic planning retreats convening stakeholders from various disciplines across KCI. The strategic plan is centered on five priority areas: immunology and immunotherapy, cancer metabolism and metabolomics, biology of cancer health disparities, addressing multilevel determinants of risk and survivorship, and increasing interventional research to reduce disparities. Administration continues to implement significant upgrades to the Research Administration Application (RAA), a homegrown repository of CCSG data for KCI. With respect to space management, Administration managed a relocation of basic science laboratories from the outdated Prentis Cancer Research Building to the renovated Elliman Research Building. Finally, Administration played a central role in the development of several large, multi-PI project grants leading to the first-ever funded SPORE grant at KCI; The Michigan Prostate SPORE (P50CA186786).

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Wayne State University
United States
Zip Code
Bock, Cathryn H; Jay, Allison M; Dyson, Gregory et al. (2018) The effect of genetic variants on the relationship between statins and breast cancer in postmenopausal women in the Women's Health Initiative observational study. Breast Cancer Res Treat 167:741-749
Hastert, T A; de Oliveira Otto, M C; LĂȘ-Scherban, F et al. (2018) Association of plasma phospholipid polyunsaturated and trans fatty acids with body mass index: results from the Multi-Ethnic Study of Atherosclerosis. Int J Obes (Lond) 42:433-440
Park, Hyo K; Schildkraut, Joellen M; Alberg, Anthony J et al. (2018) Benign gynecologic conditions are associated with ovarian cancer risk in African-American women: a case-control study. Cancer Causes Control 29:1081-1091
Heyza, Joshua; Lei, Wen; Watza, Donovan et al. (2018) Identification and characterization of synthetic viability with ERCC1 deficiency in response to interstrand crosslinks in lung cancer. Clin Cancer Res :
Mittal, Sandeep; Klinger, Neil V; Michelhaugh, Sharon K et al. (2018) Alternating electric tumor treating fields for treatment of glioblastoma: rationale, preclinical, and clinical studies. J Neurosurg 128:414-421
Paximadis, Peter; Beebe-Dimmer, Jennifer L; George, Julie et al. (2018) Comparing Treatment Strategies for Stage I Small-cell lung Cancer. Clin Lung Cancer 19:e559-e565
Su, Yongwei; Li, Xinyu; Ma, Jun et al. (2018) Targeting PI3K, mTOR, ERK, and Bcl-2 signaling network shows superior antileukemic activity against AML ex vivo. Biochem Pharmacol 148:13-26
Bonomi, Robin; Popov, Vadim; Laws, Maxwell T et al. (2018) Molecular Imaging of Sirtuin1 Expression-Activity in Rat Brain Using Positron-Emission Tomography-Magnetic-Resonance Imaging with [18F]-2-Fluorobenzoylaminohexanoicanilide. J Med Chem 61:7116-7130
Teslow, Emily A; Bao, Bin; Dyson, Greg et al. (2018) Exogenous IL-6 induces mRNA splice variant MBD2_v2 to promote stemness in TP53 wild-type, African American PCa cells. Mol Oncol 12:1138-1152
Modi, Dipenkumar; Al-Kadhimi, Zaid; Chen, Wei et al. (2018) A phase II study of tacrolimus and thymoglobulin as graft-versus-host-disease prophylaxis in related donor allogeneic hematopoietic cell transplantation. Am J Hematol 93:E96-E98

Showing the most recent 10 out of 826 publications